Interview with Jan De Backer, CEO, FluidDA
Dr De Backer looking into your background, we see that you have a background in aerospace engineering and applied biomedical computational fluid dynamics that is riddled with awards for your…
Address: Turnhoutseweg 30, B-2340 Beerse – Belgium
Tel: +32 (0)14 60 21 11
Web: http://www.janssenpharmaceutica.be/
Our Belgian branches are responsible for a number of the core activities of the Janssen Pharmaceutical Group. Various departments in Belgium are, in fact, worldwide “Centers of Excellence” (CoE’s) in their area of expertise.
The search for medicines that treat unmet medical needs continues to form the main thrust of our research activities. This means that we focus primarily on those disease areas for which no effective treatments are available yet.
Our main therapeutic areas are:
Neurosciences
Infectious diseases
Immunology
Oncology
Cardiovascular conditions
Dr De Backer looking into your background, we see that you have a background in aerospace engineering and applied biomedical computational fluid dynamics that is riddled with awards for your…
Dr De Haes, as the CEO of ThromboGenics for the last five years, can you provide us with an overview of the company’s main achievements that you are most proud…
October marks the completion of your first full year as general manager of Cegedim’s Belgian affiliate. To what extent do you feel that the skills you’ve acquired in your career…
October marks the completion of your first full year as general manager of Cegedim’s Belgian affiliate. To what extent do you feel that the skills you’ve acquired in your career…
World Courier’s General Manager, Belgium After accumulationg an almost combined five decades of experience at World Courier, can you please tell our readers what it is that attracted the both…
Mr Noel Foucart, looking into your background, we see that you have accumulated almost 3 decades of experience at World Courier. Can you tell our readers what it is that…
Today, B&M differentiates itself by what it calls its ‘fluency’ in the way you think, work and behave which enables you to navigate the legal complexities across practices and boarders…
Mr Baudier, what inspired you when you joined the company back in 1978 and what are your main goals today? Prior to joining SMB Laboratories, I worked in a publishing…
Today, B&M differentiates itself by what it calls its ‘fluency’ in the way you think, work and behave which enables you to navigate the legal complexities across practices and boarders…
What was the motivation behind the establishment of BeCRO and why was it only established in 2010 given the strength of Belgium’s clinical trials industry? Philippe van der Hofstadt: Prior…
Mr Pasini, before becoming site director of the Verviers plant you were acting as the Head of Investor Relations for Lonza. Can you provide us with an overview of your…
Having worked in internal clinical research for Eli Lilly for 14 years, from 1993 – 2007, what has this experience taught you about what pharmaceutical companies need in an outsourcing…
See our Cookie Privacy Policy Here
